Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Expert Review of Anticancer Therapy|August 19, 2025
Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysisVictoria Wytiaz, Rodney Dixon Dorand, Sean Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patientsCaryn Geady, James J Bannon, Shagheyegh Reza, et al.
JCO Precision Oncology|September 11, 2020
Oncologists' Use of Genomic Sequencing Data to Inform Clinical ManagementMichele C Gornick, Erin Cobain, Lan Q Le, et al.
Scientific Reports|July 30, 2025
Measured intrapatient radiomic variability as a predictor of treatment response in multi-metastatic soft tissue sarcoma patientsCaryn Geady, James J Bannon, Shagheyegh Reza, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Cancer Nursing|January 31, 2025
Identifying Adolescent and Young Adults' Preferences for Oncology Symptom Management Clinical Trial ParticipationRobert Knoerl, Liat Smener, Katherine Grandinetti, et al.
Journal of Adolescent and Young Adult Oncology|April 18, 2024
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured InterviewsRobert Knoerl, Katherine Grandinetti, Liat Smener, et al.
The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2010
Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumorsRobert S Benjamin, Patrick Schöffski, Jörg Thomas Hartmann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumorsGeorge D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Pageof 4